Publicacions en què col·labora amb David Ladrón de Guevara Miranda (8)

2022

  1. 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1Receptor for Parkinson's Disease

    Journal of Medicinal Chemistry, Vol. 65, Núm. 18, pp. 12256-12272

2021

  1. GABAergic deficits in absence of LPA1 receptor, associated anxiety-like and coping behaviors, and amelioration by interneuron precursor transplants into the dorsal hippocampus

    Brain Structure and Function, Vol. 226, Núm. 5, pp. 1479-1495

  2. Persistent changes in exploration and hyperactivity coexist with cognitive impairment in mice withdrawn from chronic cocaine

    Physiology and Behavior, Vol. 240

2019

  1. Lysophosphatidic acid-induced increase in adult hippocampal neurogenesis facilitates the forgetting of cocaine-contextual memory

    Addiction Biology, Vol. 24, Núm. 3, pp. 458-470

2018

  1. Systemic blockade of LPA1/3 lysophosphatidic acid receptors by ki16425 modulates the effects of ethanol on the brain and behavior

    Neuropharmacology, Vol. 133, pp. 189-201

2017

  1. The impact of cocaine on adult hippocampal neurogenesis: Potential neurobiological mechanisms and contributions to maladaptive cognition in cocaine addiction disorder

    Biochemical Pharmacology, Vol. 141, pp. 100-117

2016

  1. Cocaine-conditioned place preference is predicted by previous anxiety-like behavior and is related to an increased number of neurons in the basolateral amygdala

    Behavioural Brain Research, Vol. 298, pp. 35-43

  2. Pharmacological reduction of adult hippocampal neurogenesis modifies functional brain circuits in mice exposed to a cocaine conditioned place preference paradigm

    Addiction Biology, Vol. 21, Núm. 3, pp. 575-588